Countries are rushing to find vaccines and treatment regimens for pneumonia caused by the new corona virus, originating in Wuhan, China.
Researchers at Imperial College London, UK, on 6/2 announced a "breakthrough" in the study of the corona vaccine vaccine. It is expected that the vaccine will be tested on animals early next week.
Scientists in Australia, Singapore and Japan on February 5 also announced that they have grown a new strain of corona virus to study the vaccine and treatment regimen.
At a hospital in Bangkok, Thailand, doctors used a combination of cold and flu drugs Oseltamivir with anti-HIV drugs Lopinavir and Ritonavir in 3 patients with corona pneumonia. All three showed clear signs of recovery.
The first patient who was positive for nCoV in the US was discharged on February 3 after a successful treatment with Remdesivir. From this success, US health officials on February 6 approved the trial of Remdesivir in the treatment of corona virus pneumonia.
The team in three countries Singapore, Australia and Japan is working on replicating the new strain corona virus outside of China for the study. This promises to be a meaningful work in preparing vaccines, testing drugs and shortening the time of diagnosis.
Scientists use the isolated virus, culture with samples of positive human samples to find diagnostic methods, monitor variant signs and prepare drugs and vaccines. For the test, the researchers injected animals with a vaccine, which produced antibodies and then allowed them to infect the virus. If these antibodies defeat the pathogen, the vaccine is judged to be effective.
Number of nCoV-related cases in Vietnam
Source: vnexpress